Single Cell Nucleic Acid Analysis via Droplet Barcoding

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for analyzing mRNA content in cells, such as microarray hybridization and direct sequencing, are limited in their ability to analyze alternative splicing, promoters, and polyadenylation signals, and fail to capture functional information from single cells or observe dynamic processes like the cell cycle, due to reliance on bulk mRNA samples and lack of suitable cell-surface markers.

Innovation Solution

The development of methods and compositions for nucleic acid analysis from single cells or their organelles, using droplets and beads with unique barcodes, allowing for multiplexed single cell gene expression analysis by releasing nuclei or organelles, synthesizing cDNA, and incorporating tags for sequencing library preparation, including tagmentation to introduce barcodes and adapters.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If bulk mRNA analysis is performed using microarray hybridization or direct sequencing, then throughput and sensitivity are improved, but the ability to capture single cell variability and dynamic processes is lost

Engineering Contradiction:
ImprovethroughputVSAvoidsingle cell variability
Core Design Contradiction:
ProductivityVSLoss of information

Solution Approach 1:

The patent segments the bulk mRNA sample into individual single-cell mRNA samples by isolating single cells first. Each single cell is then processed separately to generate cDNA with unique cell-specific barcodes, allowing subsequent pooling and sequencing while preserving single-cell resolution. This segmentation enables both high throughput (by processing many cells) and retention of single-cell variability information.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent introduces cell-specific barcodes as intermediary molecular tags that link individual cells to their mRNA transcripts. These barcodes are incorporated into the cDNA during reverse transcription and serve as identifiers that allow computational separation of transcripts from different cells after pooling. This intermediary enables the system to handle bulk samples while maintaining single-cell information.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Loss of information

If single cells are isolated for study, then single cell variability can be captured, but the number of cells is insufficient to represent natural variation

Engineering Contradiction:
Improvesingle cell variabilityVSAvoidnumber of cells
Core Design Contradiction:
Loss of informationVSQuantity of substance

Solution Approach 1:

The patent merges multiple single-cell cDNA samples into a single pooled library after individual barcode assignment. By combining cDNA from many individually barcoded cells into one pool for sequencing, the method captures both single-cell resolution and population-level variation. This merging allows analysis of natural variation across large numbers of cells while maintaining the ability to trace transcripts to individual cells.

Inventive Principle:
Principle #5Merging (Combining)

3Measurement precision

If cDNA libraries are prepared from single cells, then single cell gene expression can be analyzed, but the complexity of the preparation process increases

Engineering Contradiction:
Improvesingle cell gene expression analysisVSAvoidcDNA library preparation process
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The patent employs universal primers and reagents that work across all single-cell samples simultaneously. The cell-specific barcodes are incorporated using universal reverse transcription primers, and the same pooling and sequencing protocol applies to all samples. This universality simplifies the overall process by allowing parallel processing of many cells with a single set of reagents and protocols, reducing the operational complexity despite the detailed molecular steps.

Inventive Principle:
Principle #6Universality (Multi-functionality)

4Reliability

If microarray hybridization is used for gene expression profiling, then known genes can be analyzed, but alternative splicing, promoters, and polyadenylation signals cannot be detected

Engineering Contradiction:
Improvegene expression profilingVSAvoidanalysis of alternative splicing and regulatory elements
Core Design Contradiction:
ReliabilityVSAdaptability or versatility

Solution Approach 1:

The patent replaces the microarray hybridization mechanism with direct cDNA sequencing. Instead of relying on pre-designed probes that can only detect known genes, the method uses reverse transcription to convert mRNA to cDNA followed by sequencing, which can read any nucleotide sequence. This substitution enables detection of alternative splicing variants, promoter regions, and polyadenylation signals that were invisible to microarray technology, while maintaining reliable gene expression measurement.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Enables detailed analysis of gene expression in single cells, capturing individual cell variability and dynamic processes, with improved sensitivity and throughput, allowing for whole transcriptome sequencing and digital gene expression assays.

Implementation Method 1

A first strand of cDNA is synthesized from the mRNA in each individual mRNA sample with a first strand synthesis primer

Methodology Applied
Scientific EffectReverse transcription:

Implementation Method 2

the second strand of cDNA is synthesized using the TSO primer

Methodology Applied
Scientific EffectDNA replication:

Implementation Method 3

tagmentation to introduce barcodes and adapters

Methodology Applied
Scientific EffectTransposition:

Data Source

PatentUS20210198659A1Nucleic Acid Sequence Analysis from Single Cells
Publication Date: 2021.07.01 ILLUMINA INC
  • US20210198659A1 patent drawing
  • US20210198659A1 patent drawing
  • US20210198659A1 patent drawing

AI summary

Presented herein are methods and compositions for multiplexed single cell gene expression analysis. Some methods and compositions include the use of droplets and/or beads bearing unique barcodes such as unique molecular barcodes (UMI).